Frontpage » Medications » sorted by date » page 10 »

Studies for approval of new drugs have insufficient patients to evaluate safety

For medicines intended for chronic use, the number of patients studied before regulatory approval is insufficient to properly evaluate safety and long-term efficacy, requiring the need for new legislation, according to a ...

Medications created Mar 19, 2013 | popularity not rated yet | comments 0

Court: Can generic drug maker be sued over design?

The Supreme Court will soon decide whether generic drug manufacturers can be sued in state court for a drug's design defects after federal officials approved the brand-name version.

Medications created Mar 19, 2013 | popularity not rated yet | comments 0

US warns of mold in recalled specialty drugs

The U.S. Food and Drug Administration warned doctors and hospital managers Monday about a nationwide recall of all drugs made by a New Jersey compounding pharmacy because of possible mold contamination.

Medications created Mar 18, 2013 | popularity not rated yet | comments 0

Millions of people in Asia potentially exposed to health risks of popular herbal medicines

Scientists from King's College London are warning that millions of people may be exposed to risk of developing kidney failure and bladder cancer by taking herbal medicines that are widely available in Asia. The medicines, ...

Medications created Mar 18, 2013 | popularity 1 / 5 (1) | comments 0

AstraZeneca reorg to cut 1,600 jobs in US, UK

(AP)—Struggling Anglo-Swedish drugmaker AstraZeneca PLC said Monday that it will eliminate 1,600 jobs, mostly in the U.S. and United Kingdom, as its new CEO starts a major research and development reorganization.

Medications created Mar 18, 2013 | popularity not rated yet | comments 0

A combined approach needed to fight antibiotics resistance, research says

(Medical Xpress)—In her latest report to the government, Professor Dame Sally Davies - the UK's Chief Medical Officer - says the current antibiotics resistance crisis poses a "catastrophic threat". ...

Medications created Mar 15, 2013 | popularity 4.5 / 5 (2) | comments 0 | with audio podcast

HPV vaccine trends point to failures in patient education, vaccine programs

Completion rates for the human papillomavirus (HPV) vaccine series across both genders continue to remain alarmingly low nearly seven years after its introduction, suggesting that better patient education and increased public ...

Medications created Mar 14, 2013 | popularity 5 / 5 (1) | comments 0

US probes new pancreas risks with diabetes drugs (Update)

The U.S. Food and Drug Administration is looking into new evidence that suggests a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems.

Medications created Mar 14, 2013 | popularity not rated yet | comments 0

FDA adds heart risk warning to popular antibiotic Zithromax

The Food and Drug Administration is warning doctors and patients that a widely used antibiotic from Pfizer can cause rare but deadly heart rhythms in some patients.

Medications created Mar 12, 2013 | popularity not rated yet | comments 0

Hard to find good info on drug safety in pregnancy

Nearly every woman takes a medication at some point during pregnancy. Yet there's disturbingly little easy-to-understand information about which drugs pose a risk to her baby, and what to do about it.

Medications created Mar 12, 2013 | popularity not rated yet | comments 0

FDA encourages opioid prescribers to pursue training

(HealthDay)—Prescribers of extended-release/long-acting (ER/LA) opioid analgesics are encouraged to participate in continuing medical education (CME) provided by manufacturers of these analgesics, according ...

Medications created Mar 12, 2013 | popularity not rated yet | comments 0

Interpol deal with drug firms to fight fake medicines

Interpol on Tuesday announced a deal with the world's top pharmaceutical companies to fight fake drugs which threaten the health of millions, especially in poor countries.

Medications created Mar 12, 2013 | popularity not rated yet | comments 0

US probes Sanofi over blockbuster drug Plavix (Update 2)

The U.S. Justice Department is investigating drug maker Sanofi's disclosures to the Food and Drug Administration about different responses to its blockbuster blood thinner Plavix.

Medications created Mar 11, 2013 | popularity not rated yet | comments 0

Big Pharma battle threatens to delay Pacific trade pact

A US-led Pacific free trade pact faces further delays as a row between Big Pharma and activists supporting access to generic drugs erupts ahead of an October deadline, officials say.

Medications created Mar 10, 2013 | popularity not rated yet | comments 1

Md. health official backs medical marijuana bill

(AP)—Maryland's health secretary is expressing support for a measure to allow medical marijuana in the state.

Medications created Mar 09, 2013 | popularity not rated yet | comments 0